FDA Approves First New Multiple Myeloma Drug Class in Years

A groundbreaking new cancer treatment just became available for multiple myeloma patients facing their first relapse, doubling the chances of achieving the deepest level of cancer response.

The FDA approved ZENBEXUS, the first drug in an entirely new treatment class that could transform how doctors fight this blood cancer.